grekovВестник хирургии имени И.И. ГрековаGrekov's Bulletin of Surgery0042-46252686-7370Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First St. Petersburg State Medical University» of the Ministry of Healthcare of the Russion Federation, FSBEI HE I.P.Pavlov SPbSMU MOH Russiagrekov-2287Research ArticleОБЗОРЫREVIEWSДифференциальная диагностика рака поджелудочной железы и хронического псевдотуморозного панкреатита: обзор литературыDifferential diagnosis of pancreatic cancer and chronic pseudotumor pancreatitis: literature reviewhttps://orcid.org/0000-0002-6946-9689ПерминоваА. А.PerminovaA. A.

Перминова Алина Андреевна, аспирант кафедры факультетской хирургии им. проф. А. А. Русанова, Санкт-Петербургский государственный педиатрический медицинский университет; врач-онколог онкологического отделения № 4, Городская клиническая онкологическая больница № 1 Департамента здравоохранения Москвы

194100, Санкт-Петербург, ул. Литовская, д. 2

Perminova Alina A., Postgraduate Student of the Department of Faculty Surgery named after Professor A. A. Rusanov, Saint-Petersburg State Pediatric Medical University; Oncologist, Oncology Department № 4, City Clinical Oncology Hospital № 1 

2, Litovskaya str., Saint Petersburg, 194100

al.perminova1907@yandex.ruhttps://orcid.org/0000-0002-6946-9689ХаневичМ. Д.KhanevichM. D.

Ханевич Михаил Дмитриевич, доктор медицинских наук, профессор,зав. кафедрой госпитальной хирургии

Санкт-Петербург

Khanevich Mikhail D., Dr. of Sci. (Med.), Professor, Head of the Department of Hospital Surgery

Saint Petersburg

mdkhanevich@yandex.ruМанихасГ. М.ManikhasG. M.

Манихас Георгий Моисеевич, доктор медицинских наук, профессор, профессор кафедры онкологии ФПО

Санкт-Петербург

Manikhas Georgy M., Dr. of Sci. (Med.), Professor, Professor of the Department of Oncology of the Faculty of Postgraduate Education

Saint Petersburg

mdkhanevich@yandex.ruhttps://orcid.org/0000-0002-3507-6123КоханенкоН. Ю.KokhanenkoN. Yu.

Коханенко Николай Юрьевич, доктор медицинских наук, профессор, зав. кафедрой факультетской хирургии им. проф. А. А. Русанова

Санкт-Петербург

Kokhanenko Nikolai Yu., Dr. of Sci. (Med.), Professor, Head of the Department of Faculty Surgery named after Professor A. A. Rusanov

Saint Petersburg

kohanenko@list.ruФедеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской Федерации; Государственное бюджетное учреждение здравоохранения города Москвы «Городская клиническая онкологическая больница № 1 Департамента здравоохранения города Москвы»РоссияSaint-Petersburg State Pediatric Medical University; City Clinical Oncological Hospital № 1 of the Department of Healthcare of the City of MoscowRussian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Санкт-Петербургский государственный педиатрический медицинский университет» Министерства здравоохранения Российской ФедерацииРоссияSaint-Petersburg State Pediatric Medical UniversityRussian FederationФедеральное государственное бюджетное образовательное учреждение высшего образования «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской ФедерацииРоссияPavlov UniversityRussian Federation20230111202318237782Copyright © Перминова А.А., Ханевич М.Д., Манихас Г.М., Коханенко Н.Ю., 20242024Перминова А.А., Ханевич М.Д., Манихас Г.М., Коханенко Н.Ю.Perminova A.A., Khanevich M.D., Manikhas G.M., Kokhanenko N.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.vestnik-grekova.ru/jour/article/view/2287

Каждый год случайно выявляется все больше поражений поджелудочной железы. Помимо генетической предрасположенности и факторов окружающей среды, хронический панкреатит, безусловно, является самым большим фактором риска развития злокачественной опухоли поджелудочной железы. В настоящее время отсутствуют методы скринига для  раннего выявления рака поджелудочной железы и его дифференциальной диагностики с хроническим панкреатитом. Точная характеристика поражений поджелудочной железы имеет решающее значение при принятии решения о том, следует ли использовать активную хирургическую тактику или динамическое наблюдение, какую выполнять операцию.

Every year more and more pancreatic lesions are accidentally detected. Besides genetic predisposition and environmental factors, chronic pancreatitis is by far the greatest risk factor for pancreatic malignancy. Currently, there are no screening methods for early detection of pancreatic cancer and its differential diagnosis with chronic pancreatitis. Precise characterization of pancreatic lesions is crucial in deciding whether to use active surgical tactics or dynamic observation, which surgery to perform.

хронический псевдотуморозный панкреатитрак поджелудочной железыжидкостная биопсиятонкоигольная аспирационная биопсияпанкреатодуоденальная резекцияchronic pseudotumor pancreatitispancreatic cancerliquid biopsyfine needle aspiration biopsypancreatoduodenal resectionReferencesКаприн А. Д., Старинский В. В., Шахзадова А. О. Состояние онкологической помощи населению России в 2021 году. М.: МНИОИ им. П. А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 239 с.Kaprin A. D., Starinsky V. V., Shakhzadova A. O. State of oncologic care for the Russian population in 2021. Moscow, P. A. Herzen MNIOI – branch of FGBU “NMRC Radiology” of the Ministry of Health of Russia, 2022:239.Kennedy T., Preczewski L., Stocker S. J. et al. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience // Am J Surg. 2006. Vol. 191, № 3. P. 437–441.Kennedy T., Preczewski L., Stocker S. J. et al. Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experience // Am J Surg. 2006. Vol. 191, № 3. P. 437–441.Zakaria H. M., Mohamed A., Alsebaey A., Omar H., Elazab D., Gaballa N. K. Prognostic factors following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma // Int Surg J. 2018. Vol. 5, № 12. P. 3887–3882.Zakaria H. M., Mohamed A., Alsebaey A., Omar H., Elazab D., Gaballa N. K. Prognostic factors following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma // Int Surg J. 2018. Vol. 5, № 12. P. 3887–3882.Lowenfels A. B., Maisonneuve P., Cavallini G., Ammann R. W., Lankisch P. G. et al. Pancreatitis and the risk of pancreatic cancer // International pancreatitis study group // N Engl J Med. 1993. Vol. 328. P. 1433–1437.Lowenfels A. B., Maisonneuve P., Cavallini G., Ammann R. W., Lankisch P. G. et al. Pancreatitis and the risk of pancreatic cancer // International pancreatitis study group // N Engl J Med. 1993. Vol. 328. P. 1433–1437.Talamini G., Falconi M., Bassi C., Sartori N., Salvia R. et al. Incidence of cancer in the course of chronic pancreatitis //Am J Gastroenterol. 1999. Vol. 94. P. 1253–1260.Talamini G., Falconi M., Bassi C., Sartori N., Salvia R. et al. Incidence of cancer in the course of chronic pancreatitis //Am J Gastroenterol. 1999. Vol. 94. P. 1253–1260.Birgin E., Hablawetz P., Téoule P., Rückert F., Wilhelm T. J. Chronic pancreatitis and resectable synchronous pancreatic carcinoma: a survival analysis // Pancreatology. 2018. Vol. 18. P. 394–398.Birgin E., Hablawetz P., Téoule P., Rückert F., Wilhelm T. J. Chronic pancreatitis and resectable synchronous pancreatic carcinoma: a survival analysis // Pancreatology. 2018. Vol. 18. P. 394–398.Malinka T., Klein F., Le Thu T., Rösch C.S., Wundsam H. et al. A binational analysis of 252 pancreatic resections for chronic pancreatitis with regard to incidental carcinoma sequence and overall postoperative outcome // Anticancer Res. 2018. Vol. 38. P. 4947–4952.Malinka T., Klein F., Le Thu T., Rösch C.S., Wundsam H. et al. A binational analysis of 252 pancreatic resections for chronic pancreatitis with regard to incidental carcinoma sequence and overall postoperative outcome // Anticancer Res. 2018. Vol. 38. P. 4947–4952.Munigala S., Kanwal F., Xian H., Agarwal B. New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer // American Journal of Gastroenterology. 2014. Vol. 109, № 11. P. 1824–1830.Munigala S., Kanwal F., Xian H., Agarwal B. New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer // American Journal of Gastroenterology. 2014. Vol. 109, № 11. P. 1824–1830.Gheorghe G., Bungau S., Ilie M., Behl T., Vesa C. M. et al. Early diagnosis of pancreatic cancer: The key for survival // Diagnostics. 2020. Vol.10. P. 869. DOI: 10.3390/diagnostics10110869.Gheorghe G., Bungau S., Ilie M., Behl T., Vesa C. M. et al. Early diagnosis of pancreatic cancer: The key for survival // Diagnostics. 2020. Vol.10. P. 869. DOI: 10.3390/diagnostics10110869.Gheorghe G., Diaconu C. C., Ionescu V., Constantinescu G., Bacalbasa N. et al. Risk factors for pancreatic cancer: Emerging Role of viral hepatitis // J. Pers. Med. 2022. Vol. 12. P. 83. DOI: 10.3390/jpm12010083.Gheorghe G., Diaconu C. C., Ionescu V., Constantinescu G., Bacalbasa N. et al. Risk factors for pancreatic cancer: Emerging Role of viral hepatitis // J. Pers. Med. 2022. Vol. 12. P. 83. DOI: 10.3390/jpm12010083.Han M., Tran T. P. T., Oh J. K. Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea // Sci. Rep. 2022. Vol.12. P. 5545. DOI: 10.1038/s41598-022-09426-z.Han M., Tran T. P. T., Oh J. K. Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea // Sci. Rep. 2022. Vol.12. P. 5545. DOI: 10.1038/s41598-022-09426-z.Ouyang G., Pan G., Liu Q., Wu Y., Liu Z. et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017 // BMC Med. 2020. Vol.18. P. 388. DOI: 10.1186/s12916-020-01859-5.Ouyang G., Pan G., Liu Q., Wu Y., Liu Z. et al. The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017 // BMC Med. 2020. Vol.18. P. 388. DOI: 10.1186/s12916-020-01859-5.Olesen S. S., Mortensen L. H., Zinck E., Becker U., Drewes A. M. et al. Time trends in incidence and prevalence of chronic pancreatitis: A 25- year population-based nationwide study // United Eur. Gastroenterol. J. 2020. Vol. 9. P. 82–90. DOI: 10.1177/2050640620966513.Olesen S. S., Mortensen L. H., Zinck E., Becker U., Drewes A. M. et al. Time trends in incidence and prevalence of chronic pancreatitis: A 25- year population-based nationwide study // United Eur. Gastroenterol. J. 2020. Vol. 9. P. 82–90. DOI: 10.1177/2050640620966513.Kichler A., Jang S. Chronic pancreatitis: epidemiology, diagnosis, and management updates // Drugs. 2020. Vol. 80. P. 1155–1168. DOI: 10. 1007/s40265-020-01360-6.Kichler A., Jang S. Chronic pancreatitis: epidemiology, diagnosis, and management updates // Drugs. 2020. Vol. 80. P. 1155–1168. DOI: 10. 1007/s40265-020-01360-6.Kirkegard J., Mortensen F. V., Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis // Am. J. Gastroenterol. 2017. Vol. 112. P. 1366–1372. DOI: 10.1038/ajg.2017.218.Kirkegard J., Mortensen F. V., Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: A systematic review and meta-analysis // Am. J. Gastroenterol. 2017. Vol. 112. P. 1366–1372. DOI: 10.1038/ajg.2017.218.Hollinshead K. E. R., Parker S. J., Eapen V. V., Encarnacion-Rosado J., Sohn A. et al. Respiratory supercomplexes promote mitochondrial efficiency and growth in severely hypoxic pancreatic cancer // Cell Rep. 2020. Vol. 33. P. 108231. DOI: 10.1016/j.celrep.2020.108231.Hollinshead K. E. R., Parker S. J., Eapen V. V., Encarnacion-Rosado J., Sohn A. et al. Respiratory supercomplexes promote mitochondrial efficiency and growth in severely hypoxic pancreatic cancer // Cell Rep. 2020. Vol. 33. P. 108231. DOI: 10.1016/j.celrep.2020.108231.De La Cruz M. S., Young A. P., Ruffin M. T. Diagnosis and management of pancreatic cancer // Am. Fam. Physician. 2014. Vol. 89. P. 626–632.De La Cruz M. S., Young A. P., Ruffin M. T. Diagnosis and management of pancreatic cancer // Am. Fam. Physician. 2014. Vol. 89. P. 626–632.Munigala S., Kanwal F., Xian H., Agarwal B. New diagnosis of chronic pancreatitis: Risk of missing an underlying pancreatic cancer // Am. J. Gastroenterol. 2014. Vol. 109. P. 1824–1830.Munigala S., Kanwal F., Xian H., Agarwal B. New diagnosis of chronic pancreatitis: Risk of missing an underlying pancreatic cancer // Am. J. Gastroenterol. 2014. Vol. 109. P. 1824–1830.Kitano M., Yoshida T., Itonaga M., Tamura T., Hatamaru K., Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer // J Gastroenterol. 2019. Vol. 54. P. 19–32.Kitano M., Yoshida T., Itonaga M., Tamura T., Hatamaru K., Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer // J Gastroenterol. 2019. Vol. 54. P. 19–32.Schima W., Böhm G., Rösch C. S., Klaus A., Függer R., Kopf H. Massforming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation // Cancer Imaging. 2020. Vol. 20. P. 1–12.Schima W., Böhm G., Rösch C. S., Klaus A., Függer R., Kopf H. Massforming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation // Cancer Imaging. 2020. Vol. 20. P. 1–12.Marrelli D., Caruso S., Pedrazzani C. et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions //Am J Surg. 2009. Vol. 198, № 3. P. 333–339.Marrelli D., Caruso S., Pedrazzani C. et al. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions //Am J Surg. 2009. Vol. 198, № 3. P. 333–339.Kim Y. C., Kim H. J., Park J. H. et al. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? // J Gastroenterol Hepatol. 2009. Vol. 24, № 12. P. 1869–1875.Kim Y. C., Kim H. J., Park J. H. et al. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma? // J Gastroenterol Hepatol. 2009. Vol. 24, № 12. P. 1869–1875.Liao Q., Zhao Y. P., Wu W. W., Li B. L., Li J. Y. Diagnosis and treatment of chronic pancreatitis // Hepatobiliary Pancreat Dis Int. 2003. Vol. 2, № 3. P. 445–448.Liao Q., Zhao Y. P., Wu W. W., Li B. L., Li J. Y. Diagnosis and treatment of chronic pancreatitis // Hepatobiliary Pancreat Dis Int. 2003. Vol. 2, № 3. P. 445–448.Choueiri N. E., Balci N. C., Alkaade S., Burton F. R. Advanced imaging of chronic pancreatitis // Curr Gastroenterol Rep. 2010. Vol. 12, № 2. P. 114–120.Choueiri N. E., Balci N. C., Alkaade S., Burton F. R. Advanced imaging of chronic pancreatitis // Curr Gastroenterol Rep. 2010. Vol. 12, № 2. P. 114–120.Oterdoom L. H., van Weyenberg S. J., de Boer N. K. Double-duct sign: do not forget the gallstones // J Gastrointestin Liver Dis. 2013. Vol. 22, № 4. P. 447–450.Oterdoom L. H., van Weyenberg S. J., de Boer N. K. Double-duct sign: do not forget the gallstones // J Gastrointestin Liver Dis. 2013. Vol. 22, № 4. P. 447–450.Graziani R., Tapparelli M., Malagò R. et al. The various imaging aspects of chronic pancreatitis // JOP. 2005. Vol. 6, № 1, Suppl. P. 73–88.Graziani R., Tapparelli M., Malagò R. et al. The various imaging aspects of chronic pancreatitis // JOP. 2005. Vol. 6, № 1, Suppl. P. 73–88.Ichikawa T., Sou H., Araki T. et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas // Radiology. 2001. Vol. 221, № 1. P. 107–116.Ichikawa T., Sou H., Araki T. et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas // Radiology. 2001. Vol. 221, № 1. P. 107–116.Sandrasegaran K., Nutakki K., Tahir B., Dhanabal A., Tann M., Gregory A. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer // American Journal of Roentgenology. 2013. Vol. 201. P. 1002–1008.Sandrasegaran K., Nutakki K., Tahir B., Dhanabal A., Tann M., Gregory A. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer // American Journal of Roentgenology. 2013. Vol. 201. P. 1002–1008.Garcia T. S., Engelholm J. L., Vouche M., Hirakata V. N., Leitão C. B. Intra- and interobserver reproducibility of pancreatic perfusion by computed tomography // Sci Rep. 2019. Vol. 9, № 1. P. 6043. DOI: 10.1038/s41598-019-42519-w.Garcia T. S., Engelholm J. L., Vouche M., Hirakata V. N., Leitão C. B. Intra- and interobserver reproducibility of pancreatic perfusion by computed tomography // Sci Rep. 2019. Vol. 9, № 1. P. 6043. DOI: 10.1038/s41598-019-42519-w.Li P., Deng W., Xue H., Xu K., Zhu L. et al. Weight-adapted ultra-low-dose pancreatic perfusion CT: radiation dose, image quality, and perfusion parameters // Abdom Radiol (NY). 2019. Vol. 44, № 6. P. 2196–2204. DOI: 10.1007/s00261-019-01938-z.Li P., Deng W., Xue H., Xu K., Zhu L. et al. Weight-adapted ultra-low-dose pancreatic perfusion CT: radiation dose, image quality, and perfusion parameters // Abdom Radiol (NY). 2019. Vol. 44, № 6. P. 2196–2204. DOI: 10.1007/s00261-019-01938-z.Singer E., Gschwantler M., Plattner D., Kriwanek S., Armbruster C. et al. Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera // Eur J Gastroenterol Hepatol. 2007. Vol. 19. P. 471–478.Singer E., Gschwantler M., Plattner D., Kriwanek S., Armbruster C. et al. Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera // Eur J Gastroenterol Hepatol. 2007. Vol. 19. P. 471–478.Wang Y., Miller F. H., Chen Z. E., Merrick L., Mortele K. J. et al. Diffusionweighted MR imaging of solid and cystic lesions of the pancreas // RadioGraphics. 2011. Vol. 31, № 3. P. E47–E64.Wang Y., Miller F. H., Chen Z. E., Merrick L., Mortele K. J. et al. Diffusionweighted MR imaging of solid and cystic lesions of the pancreas // RadioGraphics. 2011. Vol. 31, № 3. P. E47–E64.Wei T., Zhang X., Zhang Q., Yang J., Chen Q. et al. Vimentin positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer // Cancer Lett. 2019. Vol. 452. P. 237.Wei T., Zhang X., Zhang Q., Yang J., Chen Q. et al. Vimentin positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer // Cancer Lett. 2019. Vol. 452. P. 237.Löhr M., Müller P., Mora J., Brinkmann B., Ostwald C. et al. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis // Gastrointest Endosc. 2001. Vol. 53. P. 734–743.Löhr M., Müller P., Mora J., Brinkmann B., Ostwald C. et al. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis // Gastrointest Endosc. 2001. Vol. 53. P. 734–743.Liu X., Liu L., Ji Y., Li C., Wei T. et al. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer// EBioMedicine. 2019. Vol. 41. P. 345–56.Liu X., Liu L., Ji Y., Li C., Wei T. et al. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer// EBioMedicine. 2019. Vol. 41. P. 345–56.Radon T. P., Massat N. J., Jones R., Alrawashdeh W., Dumartin L. et al. Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma // Clin Cancer Res. 2015. Vol. 21, № 15. P. 3512–21.Radon T. P., Massat N. J., Jones R., Alrawashdeh W., Dumartin L. et al. Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma // Clin Cancer Res. 2015. Vol. 21, № 15. P. 3512–21.Zhang L., Farrell J. J., Zhou H., Elashoff D., Akin D. et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer // Gastroenterology. 2010. Vol. 138, № 3. P. 949–57.Zhang L., Farrell J. J., Zhou H., Elashoff D., Akin D. et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer // Gastroenterology. 2010. Vol. 138, № 3. P. 949–57.Liu R., Chen X., Du Y., Yao W., Shen L. et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer // Clin Chem. 2012. Vol. 58, № 3. P. 610–8.Liu R., Chen X., Du Y., Yao W., Shen L. et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer // Clin Chem. 2012. Vol. 58, № 3. P. 610–8.Nakamura S., Sadakari Y., Ohtsuka T., Okayama T., Nakashima Y. et al. Pancreatic juice exosomal MicroRNAs as biomarkers for detection of pancreatic ductal adenocarcinoma // Ann Surg Oncol. 2019. Vol. 26, № 7. P. 2104–11.Nakamura S., Sadakari Y., Ohtsuka T., Okayama T., Nakashima Y. et al. Pancreatic juice exosomal MicroRNAs as biomarkers for detection of pancreatic ductal adenocarcinoma // Ann Surg Oncol. 2019. Vol. 26, № 7. P. 2104–11.

The authors declare that there are no conflicts of interest present.